Injectable Recombinant Human Platelet-derived Growth Factor in Collagen Carrier for Hindfoot Fusion.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27871411.
- Also identified by DOI 10.1016/j.fcl.2016.07.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Arthrodesis of the hindfoot is a common procedure for degenerative joint disease and/or severe deformity. Nonunion is a common complication from this procedure, causing an increased burden to the patient and health care system, often resulting in the need for revision surgery. Recombinant human platelet-derived growth factor (rhPDGF) has been shown to be a safe and effective tool to enhance arthrodesis rates in hindfoot surgery while avoiding the potential morbidity of bone grafting. This article provides a review of the role of rhPDGF in hindfoot fusions, and the surgical technique for performing an rhPDGF enhanced double-arthrodesis through a medial approach.
Medical subject headings
- Ankle Joint
- Arthrodesis
- Collagen
- Foot
- Fractures, Ununited
- Proto-Oncogene Proteins c-sis
Anatomy
- ankle
- foot